University of Sydney research in Nature Scientific Reports has found unique molecules in the blood of MS patients could lead to the development of a definitive biomarker diagnosis. A breakthrough study led by the University of Sydney’s Brain and Mind Centre and Royal Prince Alfred Hospital has revealed unique molecules in the blood of people with Multiple Sclerosis (MS) that could become definitive diagnostic biomarkers of the world’s most common neurologic disability in young adults.
Become a Member!
– All SoP monthly magazines
– All NPT magazine archives (63 issues)
– Assorted reading and video courses
– Discounts and access to select webinars and special events
*All pricing in USD.
- Where do our minds wander? Brain waves can point the way
- Childhood neglect leaves generational imprint
- Personalized Brain Stimulation Alleviates Severe Depression Symptoms
- More Than Half of COVID-19 Healthcare Workers at Risk for Mental Health Problems
- Metabolism May Play Role in Recurrent Major Depression